I
Immunic, Inc.
IMUX · NASDAQ · Healthcare · 219M
Closing price
$8.19
+8.33% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-1.2×
Free cash flow yieldFCF yield
-67.4%
Return on equityROE
1456.2%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.2×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.